Viridian Therapeutics, Inc. VRDN Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Viridian Therapeutics, Inc. (VRDN) reported deferred tax assets and other non-current assets of $888K in Q1 2026.
- How has Viridian Therapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Viridian Therapeutics, Inc.'s deferred tax assets and other non-current assets increased by 81.6% year-over-year, from $489K to $888K.
- What is the long-term trend for Viridian Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s deferred tax assets and other non-current assets has grown at a 333.8% compound annual growth rate (CAGR), from $1K to $1.54M.